Home/Filings/4/0001209191-23-016093
4//SEC Filing

MOTT RICHARD W 4

Accession 0001209191-23-016093

CIK 0001630627other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 9:00 PM ET

Size

5.3 KB

Accession

0001209191-23-016093

Insider Transaction Report

Form 4
Period: 2022-03-01
Transactions
  • Sale

    Common Stock

    2023-03-01$21.35/sh50,000$1,067,5451,105,000 total
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.2000 to $21.5500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Includes 2,295 RSUs.

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001210226

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:00 PM ET
Size
5.3 KB